Germany's Evotec Gets Takeover Interest From Halozyme

(Bloomberg) -- Evotec SE has attracted takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc. for a deal that would ...

Germany's Evotec SE is attracting potential takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc., people familiar ...

Halozyme Makes Unsolicited €2B Takeover Bid for Drug R&D ...

Evotec's customers include Bristol Myers Squibb, Sanofi, and Novartis. Triton's accumulation of Evotec shares comes as the German company works ...

Evotec gains on Halozyme's takeover proposal - Endpoints News

Evotec's shares in Germany spiked about 18% in the early afternoon ... “The Company will carefully analyze this expression of interest ...

Evotec Receives $2.1 Billion Takeover Offer From Halozyme (2)

Evotec SE has attracted takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc. for a deal that would value the German ...

Large Pharma Partner Halozyme Therapeutics Offers To Acquire ...

Halozyme proposes €11.00/share cash acquisition of Evotec, valuing it at €2.0B, a 109% premium to October 15, 2024, price. · Proposed merger ...

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid

Investing.com -- Halozyme Therapeutics (NASDAQ:HALO) announced on Thursday its plans to acquire German drug developer Evotec SE ADR ...

Germany's Evotec Said to Get Takeover Interest From Halozyme (1)

Germany's Evotec SE is attracting potential takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc., people familiar ...

Evotec spikes on buyout proposal from Halozyme - FirstWord Pharma

The German drugmaker said that it "will carefully analyse this expression of interest" before deciding on next steps. Earlier this week, a ...

Halozyme makes 2 billion euro buyout offer for drug developer Evotec

Halozyme Therapeutics said on Thursday it has proposed to buy German drug developer Evotec ... interest-rate cut by the U.S. Federal ...

Evotec Receives Surprise €11 Takeover Bid from US Biotech ...

German biotech Evotec SE confirms unsolicited takeover interest from Halozyme Therapeutics, with a non-binding proposal of €11.00 per share.

US competitor Halozyme offers two billion euros for Evotec

The Hamburg-based biotech company Evotec has finally become a takeover candidate. The US company Halozyme Therapeutics, which operates in ...

Halozyme offers €11 per share to acquire Evotec for €2bn

The proposed acquisition of Evotec aims to merge drug delivery and discovery technologies, creating a global company with a robust pipeline ...

Evotec jumps as Halozyme confirms takeover interest (updated)

Evotec stock surges 10% as Halozyme Therapeutics expresses takeover interest, sparking investor excitement and speculation in the market.

Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per ...

PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") confirmed it has submitted a non-binding proposal to ...

DAX Update: Evotec Takeover Talks & Talanx Earnings Boost

... takeover interest from Halozyme Therapeutics. Talanx gained 7% after ... The majority of Germans are reportedly opposed to Germany playing a ...

Evotec surges on Halozyme takeover interest - Halifax – Market news

Evotec surged on Friday after Halozyme Therapeutics confirmed it had submitted a non-binding proposal to buy the German biotech for €11.00 per ...

Possible takeover battle boosts Evotec share price - MarketScreener

A possible takeover battle for Evotec boosted the share price of the drug discovery company on Friday. The US biotech company Halozyme ...

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid

Investing.com -- Halozyme Therapeutics (NASDAQ:HALO) announced on Thursday its plans to acquire German drug developer Evotec SE ADR (NASDAQ:EVO) in a deal ...

Bloomberg - The deal would value the German drug developer...

Germany's Evotec Gets Takeover Interest From Halozyme. Germany's Evotec SE is attracting potential takeover... Ivan Grabar and 6 others · 󰤥 7.